Dual Listed Biotech Begins to Prepare POC Preclinical Study for Diabetes & Obesity Dual Gene Therapy Program
04 Diciembre 2023 - 7:00AM
AllPennyStocks.com
Obesity and diabetes have become a problem for developed world
countries. To address the global rise of these issues, this company
is pursuing a dual-gene therapy strategy using
proprietary...
To read the full story on AllPennyStocks.com, click
here.
PreveCeutical Medical (CSE:PREV)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
PreveCeutical Medical (CSE:PREV)
Gráfica de Acción Histórica
De May 2023 a May 2024
